Intended for healthcare professionals

Feature Investigation

Rivaroxaban: can we trust the evidence?

BMJ 2016; 352 doi: (Published 03 February 2016) Cite this as: BMJ 2016;352:i575

Rivaroxaban: can we trust the monitoring device ?

The BMJ must continue its campaign for open access to RCT data, without fear or favour (

Sadly, in an intensely competitive Pharma world, the companies are unlikely to throw open their most intimate secrets.. but they could confirm how accurately their INR data was lab-validated ??

At least the Rocket-AF triallists have reviewed the effect of the recalled device, thus -

Competing interests: No competing interests

05 February 2016
L Sam Lewis
retired GP
Surgery, Newport, Pembrokeshire SA42 0TJ